Martian Launches Off
Kicking off this weekend’s Box Office is the critically-acclaimed blockbuster Martian. Starring Matt Damon as an astronaut trying to survive on Mars, soared to the top of the box office in its first week in theaters, taking in $54.3 million.
Martian, directed by Ridley Scott, is adapted from the novel of the same name by Andy Weir and centers on Mark Watney (Damon), an astronaut who tries to survive after being left for dead by his crewmates.
Martian received positive reviews from critics and fans, just missing another sci-fi success Gravity, which holds the record for the best October opening of all time with $55.8 million.
Several factors that prevented The Martian from topping the Clooney/Bullock blockbuster – Gravity had the benefit of several Imax locations, which were being held exclusively for Sony’s The Walk, depriving The Martian of some bonus Imax money.
The sequel, a triumphant return to form by Adam Sandler, has brought in $90.7 million in its two weeks on the silver screen. A big hit for sure, but with With Pan coming this weekend and Goosebumps the next weekend, Transylvania will have a difficult time remaining relevant.
Third place went to Sicario after recieving a nationwide expansion. The $12 million weekend was definitely a big win for Lionsgate, however Sicario did not quite live up to it performance in it’s limited run, netting a “meh” $4.6k per-screen average.
In its second week in theaters, “The Intern” dived from second to fourth, with $11.7 million in the box office.
The film stars Robert De Niro, who at 70 takes an internship at a fashion website (yawn).
Despite falling to fifth place with a $7.7 million weekend, Maze Runner: The Scorch Trials has earned enough to officially green-light the third and final film in the trilogy, Maze Runner: The Death Cure. The announcement was made last week to move forward with the follow-up to The Scorch Trials, which has earned $63.2 million in U.S. theaters over three weekends and $211 worldwide so far. The Death Cure is currently scheduled to hit theaters February 2017.
True crime biopic Black Mass, about Irish-American mobster James “Whitey” Bulger, remained roughly in the middle of the pack in its third week, at sixth place with $5.8 million. Not bad for a mobster from Massachusetts.
Mountain-climbing drama Everest earned a disapointing $5.5M, and the suprising M. Night Shyamalan’s thriller The Visit ($3.9 million), has exceeded most predictions for the film in terms of quality and sales. The final two films to sneak into the top-ten chart were the faith-based drama War Room and thriller The Perfect Guy ($2.4 million).
1. The Martian: $54.3m
2. Hotel Transylvania 2: $33.2m
3. Sicario: $12m.
4. The Intern: $11.6m
5. Maze Runner: The Scorch Trials: $7.7m
6. Black Mass: $5.8m
7. Everest: $5.5m.
8. The Visit: $3.9m
9. War Room: $2.8m
10.The Perfect Guy: $2.4m
Despite falling to fifth place with a $7.7 million weekend, Maze Runner: The Scorch Trials has apparently earned more than enough for 20th Century Fox to officially green-light the third and final film in the trilogy, Maze Runner: The Death Cure. The announcement was made last week to move forward with the follow-up to The Scorch Trials, which has earned $63.2 million in U.S. theaters over three weekends and $211 worldwide so far. The Death Cure is currently scheduled to hit theaters February 17, 2017.